tiprankstipranks
Actinium Pharmaceuticals (ATNM)
:ATNM
US Market
ATNM
Actinium Pharmaceuticals
RESEARCH TOOLSreports
Want to see ATNM full AI Analyst Report?

Actinium Pharmaceuticals (ATNM) Financial Statements

2,273 Followers

Actinium Pharmaceuticals Financial Overview

Actinium Pharmaceuticals's market cap is currently $39.53M. The company's EPS TTM is $-0.19; its P/E ratio is -1.25; Actinium Pharmaceuticals is scheduled to report earnings on March 13, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 90.00K$ 0.00$ 81.00K$ 1.03M$ 1.14M
Gross Profit$ 90.00K$ -811.00K$ 81.00K$ 1.03M$ 620.00K
Operating Income$ -36.25M$ -42.12M$ -51.92M$ -34.10M$ -24.96M
EBITDA$ -35.43M$ -37.43M$ -51.13M$ -33.41M$ -24.25M
Net Income$ -33.89M$ -38.24M$ -48.82M$ -33.02M$ -24.77M
Balance Sheet
Cash & Short-Term Investments$ 48.00M$ 72.90M$ 76.68M$ 108.91M$ 77.83M
Total Assets$ 51.77M$ 76.90M$ 81.44M$ 114.19M$ 80.39M
Total Debt$ 1.69M$ 1.57M$ 2.11M$ 2.58M$ 310.00K
Net Debt$ -46.30M$ -71.33M$ -74.56M$ -106.33M$ -77.52M
Total Liabilities$ 43.94M$ 44.14M$ 45.07M$ 47.71M$ 6.84M
Stockholders' Equity$ 7.83M$ 32.76M$ 36.38M$ 66.48M$ 73.55M
Cash Flow
Free Cash Flow$ -24.68M$ -33.08M$ -47.49M$ 8.28M$ -21.00M
Operating Cash Flow$ -24.58M$ -33.07M$ -47.34M$ 8.64M$ -20.87M
Investing Cash Flow$ -104.00K$ -11.00K$ -153.00K$ -366.00K$ -133.00K
Financing Cash Flow$ -217.00K$ 29.32M$ 14.87M$ 23.11M$ 35.22M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History

Income Statement >

Actinium Pharmaceuticals Debt to Assets

Balance Sheet >

Actinium Pharmaceuticals Cash Flow

Cash Flow >

Actinium Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >